NeueHealth, Inc.
NEUE
$6.51
$0.01830.28%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.95% | 21.21% | 18.68% | 35.52% | 46.92% |
| Total Other Revenue | -25.03% | -28.30% | -28.19% | -18.37% | -7.62% |
| Total Revenue | -13.83% | -17.91% | -19.31% | -9.01% | 1.35% |
| Cost of Revenue | -22.06% | -24.34% | -25.53% | -11.82% | 0.92% |
| Gross Profit | 28.69% | 16.96% | 18.45% | 7.01% | 3.66% |
| SG&A Expenses | -24.69% | -16.15% | -13.79% | -19.84% | -8.15% |
| Depreciation & Amortization | -14.76% | -15.72% | -14.48% | -18.42% | -31.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.62% | -22.25% | -22.60% | -14.02% | -2.21% |
| Operating Income | 82.85% | 54.88% | 45.33% | 42.28% | 21.18% |
| Income Before Tax | 89.45% | 81.21% | 84.19% | 82.33% | -103.63% |
| Income Tax Expenses | 267.63% | 201.04% | 281.86% | 131.07% | 85.10% |
| Earnings from Continuing Operations | 89.04% | 80.78% | 83.74% | 81.16% | -109.72% |
| Earnings from Discontinued Operations | 102.60% | 100.53% | 100.37% | 45.86% | 45.82% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -124.11% | -122.30% | -130.57% | 257.74% | 250.25% |
| Net Income | 91.27% | 86.85% | 88.30% | 77.26% | 26.33% |
| EBIT | 82.85% | 54.88% | 45.33% | 42.28% | 21.18% |
| EBITDA | 90.92% | 58.24% | 47.02% | 41.69% | 12.72% |
| EPS Basic | 87.09% | 83.17% | 85.00% | 75.29% | 26.16% |
| Normalized Basic EPS | -532.62% | -609.91% | -342.36% | 142.83% | 106.57% |
| EPS Diluted | 87.09% | 83.17% | 85.00% | 75.29% | 26.16% |
| Normalized Diluted EPS | -532.62% | -609.91% | -342.36% | 142.83% | 106.57% |
| Average Basic Shares Outstanding | 5.56% | 4.25% | 3.31% | 2.78% | 2.16% |
| Average Diluted Shares Outstanding | 5.56% | 4.25% | 3.31% | 2.78% | 2.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |